๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Gellan in sustained release formulations: preparation of gel capsules and release studies

โœ Scribed by F. Alhaique; E. Santucci; M. Carafa; T. Coviello; E. Murtas; F.M. Riccieri


Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
698 KB
Volume
17
Category
Article
ISSN
0142-9612

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Preparation and evaluation of eudragit g
โœ Nak-Seo Kim; Masakazu Kawata; Takahiro Uchida; Shigeru Goto ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 484 KB

A novel method was established for the preparation of Eudragit S, Eudragit L, and Eudispert high-viscosity (hv) hydrogel and xerogel preparations containing a medicinal component such as pentoxifylline (an agent that improves cerebral microcirculation). A significant correlation was found between th

Pharmacokinetic principles in the design
โœ Wing K. Cheung; B. Michael Silber; Avraham Yacobi ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 567 KB

The potential advantages and disadvantages of incorporating an immediate-release (IR) component in sustained-release formulations with zero-order release characteristics (SR) are discussed. The dose of the IR component for SR doses other than the first one (DIS) should be less than that for the firs

Preparation and evaluation of micro-poro
โœ Y. Yoshikawa; A. Kawai; H. Yasui; H. Yoshikawa; K. Takada ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 163 KB ๐Ÿ‘ 1 views

Micro-porous ethylcellulose (EC) membrane capsules were prepared by dissolving polyvinylalcohol (PVA) particles from membranes which were made of a mixture of EC (a water-insoluble polymer). The pore size was approximately 400 mm. Since the dissolution rate of theophylline from the micro-porous EC m

A comparative bioavailability study on t
โœ L. Erlacher; H. Templ; D. Magometschnigg ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 436 KB

In 12 healthy volunteers the pharmacokinetic parameters of two new sustained-release formulations of disodiummonofluorophosphate (MFP) (B and C) were compared with those of a nonsustained-release reference preparation (A). This randomized study had a single-dose, triple-cross over design and consist